Fatigue News and Research

RSS

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.

25 Jun 2018

Many female preschool teachers suffer from hearing-related problems

Seven out of ten female preschool teachers suffer from sound-induced auditory fatigue, one out of two has difficulty understanding speech and four out of ten become hypersensitive to sound. This is a considerably higher share than among women in general and also higher than in occupational groups exposed to noise, according to research at Sahlgrenska Academy, Sweden.

25 Jun 2018

Loyola Medicine study: Floppy eyelids linked to sleep apnea

A Loyola Medicine study is providing further evidence that floppy eyelids may be a sign of sleep apnea.

19 Jun 2018

Scientists discover new mechanism controlling multiple sclerosis risk

While the DNA sequence remains the same throughout a person's life, the expression of the encoded genes may change with time and contribute to disease development in genetically predisposed individuals.

19 Jun 2018

Study: Rheumatoid Arthritis patients with depression have increased risk of disease flare

Research from the Department of Inflammation Biology, School of Immunology & Microbial Sciences has shown there is an increased risk of disease flare in Rheumatoid Arthritis patients who suffer from depression.

19 Jun 2018

Researchers examine risk factors for opioid dependence in patients undergoing surgery for DS

Researchers investigated risk factors for the development of opioid dependence in patients undergoing surgery for degenerative spondylolisthesis

19 Jun 2018

Late onset of diabetes could be indicative of pancreatic cancer

Onset of pancreas cancer after the age of 50 years could be a sign of development of pancreatic cancer finds a new study.

18 Jun 2018

New study examines how the brain plays role in rheumatoid arthritis inflammation

In patients with chronic inflammatory conditions, such as rheumatoid arthritis, there has been limited understanding of how this inflammation affects the brain.

18 Jun 2018

Study finds increased risk of mortality in people with cold agglutinin disease in five years after diagnosis

Bioverativ Inc., a Sanofi company dedicated to transforming the lives of people with rare blood disorders, today announced results from a new, population-based retrospective study that found a greater than twofold increased risk of mortality in people with cold agglutinin disease within the first five years after diagnosis.

18 Jun 2018

New study highlights predictors that prevent from achieving remission in early RA

The results of a study presented today at the Annual European Congress of Rheumatology report that obesity in women and current smoking in men were the strongest predictors of not achieving remission in early rheumatoid arthritis within a year.

18 Jun 2018

New studies help elucidate role of sleep in chronic pain

The results of two studies presented today at the Annual European Congress of Rheumatology provide insight into the role of sleep in chronic pain.

18 Jun 2018

Etiologies of growing pains

If you are a parent who has been awakened from slumber with a child crying in pain, you can understand my distress at watching my son wake up in pain night after night.

14 Jun 2018

New FDA-approved therapy provides better quality of life for patients with midgut neuroendocrine tumors

Midgut neuroendocrine tumors are a rare type of cancer that develops in the small intestine and colon. Roughly 12,000 people are diagnosed with this disease each year. In January, the United Stated Food and Drug Administration approved Lutathera, a first-of-its-kind peptide receptor radionuclide therapy.

12 Jun 2018

Research aims to better understand psychological mechanisms of hunger-induced emotional states

What makes someone go from simply being hungry to full-on "hangry"? More than just a simple drop in blood sugar, this combination of hunger and anger may be a complicated emotional response involving an interplay of biology, personality and environmental cues, according to research published by the American Psychological Association.

11 Jun 2018

Moderate and extreme temperature exposures may increase risk of occupational accidents

Moderate and extreme ambient temperatures increase the risk of occupational accidents. This is the main conclusion of a new study by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Banking Foundation.

11 Jun 2018

Customized resistance exercise helps female fibromyalgia patients improve health

Fibromyalgia and resistance exercise have often been considered an impossible combination. But with proper support and individually adjusted exercises, female patients achieved considerable health improvements, according to research carried out at Sahlgrenska Academy, Sweden.

8 Jun 2018

Study finds factors that help or hinder patient involvement in clinical trials of mitochondrial disease

As clinical trials gear up with the aim of attaining the first FDA-approved treatments for mitochondrial disease, a new study reports for the first time what patients and families say would motivate them for or against participating in such research trials.

7 Jun 2018

Childhood cancer survivors have increased odds for sleep problems as adults

Preliminary results from a study of childhood cancer survivors show that they are more likely to experience sleep problems and daytime sleepiness as adults, and those who report poor sleep have a greater likelihood of persistent or worsened emotional distress.

4 Jun 2018

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Bristol-Myers Squibb Company today announced patient-reported outcomes data from the Phase 3 CheckMate -214 trial in intermediate- and poor-risk patients with advanced renal cell carcinoma treated with the Immuno-Oncology combination Opdivo plus low-dose Yervoy versus sunitinib over a two-year follow-up period.

1 Jun 2018

Depression symptoms can get worse without proper treatment

While it is common for everyone to feel down or sad at times, a person whose symptoms last for more than two weeks may be having a major depressive episode, according to The Substance Abuse and Mental Health Services Administration.

31 May 2018

Fatigue News and Research

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Many female preschool teachers suffer from hearing-related problems

Loyola Medicine study: Floppy eyelids linked to sleep apnea

Scientists discover new mechanism controlling multiple sclerosis risk

Study: Rheumatoid Arthritis patients with depression have increased risk of disease flare

Researchers examine risk factors for opioid dependence in patients undergoing surgery for DS

Late onset of diabetes could be indicative of pancreatic cancer

New study examines how the brain plays role in rheumatoid arthritis inflammation

Study finds increased risk of mortality in people with cold agglutinin disease in five years after diagnosis

New study highlights predictors that prevent from achieving remission in early RA

New studies help elucidate role of sleep in chronic pain

Etiologies of growing pains

New FDA-approved therapy provides better quality of life for patients with midgut neuroendocrine tumors

Research aims to better understand psychological mechanisms of hunger-induced emotional states

Moderate and extreme temperature exposures may increase risk of occupational accidents

Customized resistance exercise helps female fibromyalgia patients improve health

Study finds factors that help or hinder patient involvement in clinical trials of mitochondrial disease

Childhood cancer survivors have increased odds for sleep problems as adults

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Depression symptoms can get worse without proper treatment

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News